Targeting C5a Doesn't Help Ventilated COVID Patients ... or Does It?

(MedPage Today) -- An anti-C5a antibody failed to show a statistically significant mortality reduction in critically ill, ventilated COVID-19 patients in a phase III trial, but investigators say the results still point to a benefit with the investigational...